These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10441607)

  • 1. Drug treatment of lipid disorders.
    Knopp RH
    N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of the treatment for hyperlipidemia.
    Malinow MR
    Cardiol Clin; 1986 Feb; 4(1):95-103. PubMed ID: 3518936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL = 5: Virtues and dangers of multidrug therapy of low-density lipoprotein cholesterol.
    Phillips W; Schaefer S
    Prev Cardiol; 2010; 13(2):69-71. PubMed ID: 20377808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug combination therapies for patients with hyperlipidemia and its significance].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133
    [No Abstract]   [Full Text] [Related]  

  • 6. Current drug treatments for lipid management.
    Stone NJ
    Manag Care; 2002 Sep; 11(9 Suppl):4-9. PubMed ID: 12369341
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia treatment in children: the younger, the better.
    Gauer R
    Am Fam Physician; 2010 Sep; 82(5):460. PubMed ID: 20822078
    [No Abstract]   [Full Text] [Related]  

  • 8. Common obstacles in lipid management.
    Elpers M
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):287-95. PubMed ID: 18644511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications and side effects. Crestor tested in PHAs.
    TreatmentUpdate; 2005; 17(4):6-7. PubMed ID: 17230630
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid lowering therapy for adults with diabetes.
    Jackowski L; Crockett J; Rowett D
    Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid screening and cardiovascular health in childhood.
    Daniels SR; Greer FR;
    Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

  • 14. Choosing drug therapy for patients with hyperlipidemia.
    Safeer RS; Lacivita CL
    Am Fam Physician; 2000 Jun; 61(11):3371-82. PubMed ID: 10865931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL; Blazing MA; Saxena S; Guyton JR
    J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current dietetic and pharmacological treatment of hyperlipoproteinemia].
    Caruzzo C
    Minerva Med; 1975 Dec; 66(84):4527-34. PubMed ID: 1105243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
    Ginsberg HN; Stalenhoef AF
    J Cardiovasc Risk; 2003 Apr; 10(2):121-8. PubMed ID: 12668909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?
    Drexel H
    Fundam Clin Pharmacol; 2009 Dec; 23(6):687-92. PubMed ID: 19682084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.